Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries has said that the FDA has granted tentative approval for the company's abbreviated new drug application to market its generic version of Lilly's osteoporosis treatment Evista tablets, 60mg.
Subscribe to our email newsletter
Teva is currently involved in patent litigation concerning this product in the US District Court of Indiana. A trial date has not been set.